Follow
Xu Li
Xu Li
Zymeron Corporation
Verified email at zymeron.com
Title
Cited by
Cited by
Year
A mesoporous silica nanoparticle–PEI–fusogenic peptide system for siRNA delivery in cancer therapy
X Li, Y Chen, M Wang, Y Ma, W Xia, H Gu
Biomaterials 34 (4), 1391-1401, 2013
2872013
The packaging of siRNA within the mesoporous structure of silica nanoparticles
X Li, QR Xie, J Zhang, W Xia, H Gu
Biomaterials 32 (35), 9546-9556, 2011
2012011
Synthesis and characterization of pore size-tunable magnetic mesoporous silica nanoparticles
J Zhang, X Li, JM Rosenholm, H Gu
Journal of colloid and interface science 361 (1), 16-24, 2011
1742011
Adsorption and desorption behaviors of DNA with magnetic mesoporous silica nanoparticles
X Li, J Zhang, H Gu
Langmuir 27 (10), 6099-6106, 2011
1592011
Control of aggregate size of polyethyleneimine-coated magnetic nanoparticles for magnetofection
X Wang, L Zhou, Y Ma, X Li, H Gu
Nano Research 2, 365-372, 2009
1392009
Lipid-enveloped hybrid nanoparticles for drug delivery
S Tan, X Li, Y Guo, Z Zhang
Nanoscale 5 (3), 860-872, 2013
1342013
Lipid nanoparticles with minimum burst release of TNF-α siRNA show strong activity against rheumatoid arthritis unresponsive to methotrexate
AM Aldayel, HL O'Mary, SA Valdes, X Li, SG Thakkar, BE Mustafa, Z Cui
Journal of Controlled Release 283, 280-289, 2018
972018
Study on the adsorption mechanism of DNA with mesoporous silica nanoparticles in aqueous solution
X Li, J Zhang, H Gu
Langmuir 28 (5), 2827-2834, 2012
912012
Endosomal escape kinetics of mesoporous silica-based system for efficient siRNA delivery
M Wang, X Li, Y Ma, H Gu
International journal of pharmaceutics 448 (1), 51-57, 2013
672013
Combination delivery of Adjudin and Doxorubicin via integrating drug conjugation and nanocarrier approaches for the treatment of drug-resistant cancer cells
X Li, C Gao, Y Wu, CY Cheng, W Xia, Z Zhang
Journal of materials chemistry B 3 (8), 1556-1564, 2015
602015
Toward understanding the mechanism underlying the strong adjuvant activity of aluminum salt nanoparticles
TB Ruwona, H Xu, X Li, AN Taylor, Y Shi, Z Cui
Vaccine 34 (27), 3059-3067, 2016
572016
Acid-sensitive sheddable PEGylated PLGA nanoparticles increase the delivery of TNF-α siRNA in chronic inflammation sites
AM Aldayel, YW Naguib, HL O'mary, X Li, M Niu, TB Ruwona, Z Cui
Molecular Therapy-Nucleic Acids 5, 2016
492016
Aluminum (oxy) hydroxide nanosticks synthesized in bicontinuous reverse microemulsion have potent vaccine adjuvant activity
X Li, S Hufnagel, H Xu, SA Valdes, SG Thakkar, Z Cui, H Celio
ACS applied materials & interfaces 9 (27), 22893-22901, 2017
442017
Zoledronic acid-containing nanoparticles with minimum premature release show enhanced activity against extraskeletal tumor
X Li, SA Valdes, RF Alzhrani, S Hufnagel, SD Hursting, Z Cui
ACS applied materials & interfaces 11 (7), 7311-7319, 2019
312019
In vivo distribution of zoledronic acid in a bisphosphonate-metal complex-based nanoparticle formulation synthesized by a reverse microemulsion method
X Li, YW Naguib, Z Cui
International journal of pharmaceutics 526 (1-2), 69-76, 2017
292017
Reverse Microemulsion-Based Synthesis of (Bis) phosphonate–Metal Materials with Controllable Physical Properties: An Example Using Zoledronic Acid–Calcium Complexes
X Li, YW Naguib, S Valdes, S Hufnagel, Z Cui
ACS applied materials & interfaces 9 (16), 14478-14489, 2017
202017
Uric acid and the vaccine adjuvant activity of aluminium (oxy) hydroxide nanoparticles
SG Thakkar, H Xu, X Li, Z Cui
Journal of drug targeting 26 (5-6), 474-480, 2018
192018
Acid-sensitive sheddable PEGylated, mannose-modified nanoparticles increase the delivery of betamethasone to chronic inflammation sites in a mouse model
HL O’Mary, AM Aldayel, SA Valdes, YW Naguib, X Li, K Salvady, Z Cui
Molecular pharmaceutics 14 (6), 1929-1937, 2017
162017
Adsorption Isotherm Measurement Correction of DNA onto Silica Sphere
Q Min, L Xu, G Hong-Chen
CHINESE JOURNAL OF ANALYTICAL CHEMISTRY 38 (7), 963-967, 2010
2010
The system can't perform the operation now. Try again later.
Articles 1–19